LabCorp stops selling OvaSure to appease FDA
This article was originally published in Clinica
Executive Summary
Laboratory Corporation of America ( LabCorp) has voluntarily stopped selling its OvaSure ovarian cancer test after the company was criticised by the FDA for marketing the product without regulatory approval.